ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $183,236 | +11.2% | 7,214 | -0.8% | 0.00% | 0.0% |
Q4 2023 | $164,852 | +21.1% | 7,275 | -0.4% | 0.00% | 0.0% |
Q3 2023 | $136,092 | -33.4% | 7,305 | -7.1% | 0.00% | 0.0% |
Q2 2023 | $204,359 | -10.6% | 7,866 | -1.2% | 0.00% | -50.0% |
Q1 2023 | $228,611 | -2.5% | 7,960 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $234,550 | +23.4% | 7,924 | -0.8% | 0.00% | +100.0% |
Q3 2022 | $190,000 | +8.0% | 7,986 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $176,000 | -15.4% | 7,895 | -4.5% | 0.00% | 0.0% |
Q1 2022 | $208,000 | -33.8% | 8,269 | -5.8% | 0.00% | -50.0% |
Q4 2021 | $314,000 | -18.4% | 8,776 | -3.1% | 0.00% | 0.0% |
Q3 2021 | $385,000 | -5.2% | 9,056 | -3.3% | 0.00% | +100.0% |
Q2 2021 | $406,000 | +6.6% | 9,368 | +0.4% | 0.00% | 0.0% |
Q1 2021 | $381,000 | -10.8% | 9,330 | -1.0% | 0.00% | -50.0% |
Q4 2020 | $427,000 | +24.9% | 9,427 | -2.4% | 0.00% | 0.0% |
Q3 2020 | $342,000 | -8.6% | 9,663 | -2.4% | 0.00% | 0.0% |
Q2 2020 | $374,000 | +39.0% | 9,900 | +6.5% | 0.00% | +100.0% |
Q1 2020 | $269,000 | -46.8% | 9,296 | -4.7% | 0.00% | -50.0% |
Q4 2019 | $506,000 | -7.5% | 9,754 | -2.2% | 0.00% | 0.0% |
Q3 2019 | $547,000 | +29.6% | 9,973 | -4.1% | 0.00% | 0.0% |
Q2 2019 | $422,000 | +32.7% | 10,397 | -1.3% | 0.00% | +100.0% |
Q1 2019 | $318,000 | -12.4% | 10,531 | -2.6% | 0.00% | 0.0% |
Q4 2018 | $363,000 | -23.4% | 10,815 | -3.7% | 0.00% | -50.0% |
Q3 2018 | $474,000 | +32.8% | 11,232 | +0.8% | 0.00% | +100.0% |
Q2 2018 | $357,000 | -21.9% | 11,141 | +21.2% | 0.00% | -50.0% |
Q1 2018 | $457,000 | -26.1% | 9,190 | -19.8% | 0.00% | 0.0% |
Q4 2017 | $618,000 | -6.6% | 11,466 | +0.4% | 0.00% | 0.0% |
Q3 2017 | $662,000 | +24.2% | 11,419 | +5.7% | 0.00% | 0.0% |
Q2 2017 | $533,000 | +41.4% | 10,801 | +24.5% | 0.00% | +100.0% |
Q1 2017 | $377,000 | -26.1% | 8,675 | -16.7% | 0.00% | -50.0% |
Q4 2016 | $510,000 | -99.9% | 10,411 | -1.7% | 0.00% | 0.0% |
Q3 2016 | $506,923,000 | -10.2% | 10,594 | +0.6% | 0.00% | 0.0% |
Q2 2016 | $564,774,000 | +15.0% | 10,527 | -4.2% | 0.00% | 0.0% |
Q1 2016 | $491,000,000 | +22.1% | 10,983 | +4.3% | 0.00% | 0.0% |
Q4 2015 | $402,000,000 | +120984.3% | 10,534 | +1.1% | 0.00% | +100.0% |
Q3 2015 | $332,000 | -99.9% | 10,419 | +0.6% | 0.00% | 0.0% |
Q2 2015 | $342,059,000 | -34.2% | 10,356 | -18.0% | 0.00% | -50.0% |
Q1 2015 | $519,894,000 | +7.7% | 12,628 | +6.5% | 0.00% | 0.0% |
Q4 2014 | $482,891,000 | +8.3% | 11,853 | -2.5% | 0.00% | 0.0% |
Q3 2014 | $445,785,000 | -10.3% | 12,160 | +13.4% | 0.00% | 0.0% |
Q2 2014 | $496,936,000 | +25.2% | 10,726 | +11.0% | 0.00% | 0.0% |
Q1 2014 | $397,026,000 | +4.6% | 9,660 | -2.8% | 0.00% | 0.0% |
Q4 2013 | $379,425,000 | +96.6% | 9,943 | +23.5% | 0.00% | +100.0% |
Q3 2013 | $192,950,000 | +39.9% | 8,053 | -0.8% | 0.00% | 0.0% |
Q2 2013 | $137,938,000 | – | 8,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |